Patent details

EP3331894 Title: NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES AND THEIR USES

Basic Information

Publication number:
EP3331894
PCT Application Number:
US2016045855
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP168339570
PCT Publication Number:
WO2017024255
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES AND THEIR USES
French Title of Invention:
DÉRIVÉS DE NICOTINAMIDE MONONUCLÉOTIDE ET LEUR UTILISATIONS
German Title of Invention:
NICOTINAMID-MONONUKLEOTIDDERIVATE UND DEREN VERWENDUNGEN
SPC Number:

Dates

Filing date:
05/08/2016
Grant date:
17/02/2021
EP Publication Date:
13/06/2018
PCT Publication Date:
09/02/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
17/02/2021
EP B1 Publication Date:
17/02/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
05/08/2021
Expiration date:
05/08/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
10/02/2021
 
 

Name:
Metro International Biotech, LLC
Address:
540 Hawthorne Street, Birmingham, MI 48009, United States (US)

Inventor

1

Name:
SZCZEPANKIEWICZ, Bruce
Address:
United States (US)

2

Name:
LIVINGSTON, David
Address:
United States (US)

3

Name:
SINCLAIR, David A.
Address:
United States (US)

4

Name:
MCKEARIN, James, M.
Address:
United States (US)

5

Name:
KREMSKY, Jonathan, N.
Address:
United States (US)

6

Name:
NORMINGTON, Karl D.
Address:
United States (US)

Priority

Priority Number:
201562201447 P
Priority Date:
05/08/2015
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/443; A61K 31/661; A61K 31/665; A61P 3/00; A61P 3/08; A61P 9/00; A61P 17/00; A61P 25/28; A61P 31/12; A61P 35/00; A61P 43/00; C07F 9/06; C07F 9/547; C07H 11/04;

Publication

European Patent Bulletin

1

Issue number:
202107
Publication date:
17/02/2021
Description:
Grant (B1)

2

Issue number:
202151
Publication date:
22/12/2021
Description:
Opposition procedure started

3

Issue number:
202328
Publication date:
12/07/2023
Description:
Opposition rejected; Patent maintained as granted

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages